(NYSE: BMY) Bristol Myers Squibb Co's forecast annual revenue growth rate of -0.14% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.98%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.
Bristol Myers Squibb Co's revenue in 2024 is $45,006,000,000.On average, 7 Wall Street analysts forecast BMY's revenue for 2024 to be $93,092,757,571,053, with the lowest BMY revenue forecast at $91,828,656,159,129, and the highest BMY revenue forecast at $94,480,111,671,378. On average, 7 Wall Street analysts forecast BMY's revenue for 2025 to be $93,436,504,162,409, with the lowest BMY revenue forecast at $91,333,944,740,869, and the highest BMY revenue forecast at $97,043,848,477,843.
In 2026, BMY is forecast to generate $90,006,585,074,662 in revenue, with the lowest revenue forecast at $85,117,206,536,135 and the highest revenue forecast at $98,977,874,256,124.